PI3K/AKT/mTOR pathway-related gene alterations involved in the pathogenesis of Endometriosis and Endometriosis-Associated Ovarian Cancer
PI3K/AKT/mTOR pathway-related gene alterations involved in the pathogenesis of Endometriosis and Endometriosis-Associated Ovarian Cancer. Normal uterine epithelium harboring activating mutations in PIK3CA, AKT1, ERBB2, and PIK3R1 and is correlated with a higher tendency towards endometriosis development [30,32,33,34], while endometriotic epithelium carrying additional activating mutations in PIK3CA and inactivating mutations in PTEN and ARID1A is more likely to undergo malignant transformation [35]. Molecules depicted in green are components of the PI3K/AKT/mTOR signaling pathway. ARID1A, depicted in purple, does not actively participate in mTOR signaling, but closely interacts with it, in such a way that loss of ARID1A expression probably allows the function of the mTOR pathway, which is enhanced by the aforementioned genetic alterations, to induce carcinogenesis in ovarian endometriotic cysts. PIK3CA, Phosphatidylinositol-4,5-bisphosphate 3-kinase catalytic subunit alpha; AKT1, RAC-Alpha serine/threonine-protein kinase; ERBB2, Human epidermal growth factor receptor 2; PIK3R1, Phosphoinositide-3-kinase regulatory subunit 1; PTEN, Phosphatase, and tensin homolog; ARID1A, AT-rich interaction domain 1A